Skip to main content
Search
Mose

Mose

  
Mose > Life science conference  

Life science conference

 
Home
Multiscale Molecular Modeling
MOSE Staff
Publications
Conference proceeding
Conferences & Seminars
Research projects
 
Life science conference
#YearAuthorsReferenceTopicTitle
4532010Pricl SConference CDACS - American Chemical Society, Boston, USIs variety the spice of life?
4542010Pricl S., Posocco P., Fermeglia M., Karatasos K., Peng L., Smith D.K.Conference CDAIChE Annual Meeting 2010, American Institute of Chemical Engineering, Salt Lake City, USThe Sound of Silence. Multiscale Molecular Simulations and Experiments in Developing Nanocarrier/Nucleic Acid Systems
4562010Pricl S., Posocco P., Laurini E., Fermeglia M., Karatasos K., Peng L., Smith D.K.Conference CD and WebNanotechItaly, Convegno Italiano di Nanotecnologie, Venezia, IWhen virtual and real meet: computational/experimental evidences for designing efficient nanovectors for siRNA/DNA delivery
4202009Posocco P., Fermeglia M., Pricl S.FOMMS2009, Foundation of Molecular Modelling and Simulation, Semiahmoo Resort Blane, Washington, USAMulholland Dr. Multiscale molecular modeling of the self-assembly of di/triblock copolymers for drug delivery
4212009Pricl S., Posocco P., Pavan G.M., Fermeglia M., Scocchi G., Malek A., Maly M., Danani A., Catapano C., Peng L., Smith D.K.FOMMS2009, Foundation of Molecular Modelling and Simulation, Semiahmoo Resort Blane, Washington, USAThe sound of silence. Experimental/computational investigations of dendrimer-based sirna/dna delivery systems
3942008Posocco P., Pavan G., Scocchi G., Handgraaf J.W., Malek A., Maly M., Fermeglia M., Fraaije J., Catapano V., Danani A., Pricl S.57: 154-159 (2008)CIMTEC 2008, 3rd International Conference on SMART MATERIALS, STRUCTURES AND SYSTEMS, Acireale, ItalyLink to PDF DocumentBase Invaders. Coupling Experiments and Multiscale Modeling of Dendrimer-Based siRNA Delivery Agents
3882008Fermeglia M., Pricl S.1: 61 (2008)Drug Design and Discovery for Developing Countries, ICS-UNIDO. Trieste, IMultiscale molecular strategies for drug delivery
4192008Fermeglia M., Pricl S.CD (2008)Drug Design and Discovery for Developing Countries, ICS-UNIDO. Trieste, IMultiscale Molecular Strategies for Drug Delivery
4152008Paneni M.S., Posocco P., De Santo I., Causa F., Netti P.A., Pricl S.NNC: National nanomedicne Conference, Genova, 28-29 February 2008Nanochannels versus macromolecules:a multiscale computational approch of macromolecular transport in confined nanospaces
3532007Posocco P., Scocchi G., Fermeglia M., Pricl S., Ferrari M.1:113 (2007)11th International Conference on Properties and Phase Equilibria for Product and Process Design PPEPPD, Crete, Greece, 2007The nanoroad less travelled. A multiscale approach to self-assembly of dendrimers for cancer therapy
3542007Posocco P., Paneni M.S., Pricl Sx: xx-xx (2007)XVI International HIV DRUG RESISTANCE Workshop, Hilton Barbados, Barbados, 2007Non-Nucleoside RT Inhibitors (NNRTIs) research: Breaking Down Resistance Using Advanced Computational Procedures
3052006Pricl S., Ferrone M., Cosoli P., Paneni M.S., Fermeglia M., Cosentino C., Amato F., Cheng M.C.C., Ferrari M.53: 79-84 (2006)11th International Conferences on Modern Materials and Technologies CIMTEC, Acireale, IT, 2006Link to PDF DocumentRelease of Proteins from Nanochannel Delivery Systems: a Coupled Many-Scale Simulation - Experimental Investigation
3352006Pricl S., Fermeglia M., Tamborini E., Pierotti M.A., Pilotti S.1: 68 (2006)18th EORTC-NCI-AACR Symposium on "Molecular Targets and Cancer Therapeutics", Prague, Cz,Link to PDF DocumentEquilibrium on hold. A computational rationale for the role of kit juxtamembrane mutations in controlling receptor autophosphorylation
3472006Pricl S., Ferrone M., Paneni M.S., Cosoli P., Fermeglia M., Perrone F., Da Riva L., Tamborini E., Suardi S., Pierotti M.P., Pilotti S.CD 1: 1556 (2006)97th AACR Annual Meeting, Washington, DC, US, 2006Link to PDF DocumentAngels and demons of the guardian of the genome. A coupled modeling-biochemical study of p53 mutants in ovarian cancer
3292006Pricl S., Salvatori G., Shehata N.1: 71 (2006)Ceramic, Cell and Tissue 10th Annual Seminar & Meeting - materials for scaffolding of biologically engineered systems, Faenza, ItalyWhich kinds of drugs? Which kind of actions?
3302006Fermeglia M., Ferrone M., Cosoli P., Paneni M.S., Cosentino C., Amato F., Cheng M.M.C., Walczak R., Pricl S., Ferrari M.CD 1: 43 (2006)FOMMS2006, Foundation of Molecular Modelling and Simulation, Semiahmoo Resort Blane, Washington, USALink to PDF DocumentDelivered to Perfection at Nanoscale. A Coupled Multiscale Simulation/Experimental Investigation of Protein Release from Nanochannel Delivery Systems
3462006Ferrone M., Fermeglia M., Paneni M.S., Pierotti M.A., Pilotti S., Tamborini E. , Pricl S.CD 1: 41 (2006)FOMMS2006, Foundation of Molecular Modelling and Simulation, Semiahmoo Resort Blane, Washington, USALink to PDF DocumentOf life and Death: Chronic Myeloid Leukemia and the Bcr-Abl/Imatinib Paradigm
3502006Pricl S., Ferrone M., Posocco P., Pavan G.M., Fermeglia M., La Colla P., Loddo R.1: 62-63 (2006)HIV DART 2006: Frontiers in drug development for antiretroviral therapies, Cancun, Mexico, 2006Link to PDF DocumentA new twist for an old song. The DABO story revisited
3512006Pricl S., Ferrone M., Posocco P., Fermeglia M., Sanna G., Collu G., La Colla P., Loddo R., Sias A., Piras S., Carta A.1: 63 (2006)HIV DART 2006: Frontiers in drug development for antiretroviral therapies, Cancun, Mexico, 2006Link to PDF DocumentChasing the evaders. Design, synthesis, activity and molecular modelling of a new small molecule with activity against drug-resistant HIV-1-mutants
3362006Pricl S., Fermeglia M., Tamborini E., Pierotti M.A., Pilotti S.1: 47 (2006)Targeted therapies in cancer: myth or realty? Milan, ItalyLink to PDF DocumentActivity of PKC412 against an Imatinib-resistant gastrointestinal stromal tumor (GIST) carrying a D842V mutation in PDGFR: a combined clinical/modeling study
3072005Toth R., Ferrone M., Miertus S., Chiellini E., Fermeglia M., Pricl S.1: 217 (2005)29th International Conference on Solution Chemistry, Portoroz, Slovenija, 2005Link to PDF DocumentSimulation insight on the structure and energetics of biocompatible polymer nanocomposite systems
2982005Pricl S:, Tamborini E., Ferrone M., Paneni M.S., Fermeglia M., Pierotti M.A., Pilotti S.Proceedings Supplement 1: 30-31 (2005)AACR Annual Meeting, Anaheim, CA, US, 2005Link to PDF DocumentCan computational structural biology be of help in rationalizing clinical data? The Abl/imatinib paradigm
2992005Tamborini E., Pricl S., Negri T., Lagonigro M.S., Gabanti E., Greco A., Dagrada G., Miselli F., Ferrone M., Pierotti M.A., Pilotti S.Proceedings Supplement 1: 147-148 (2005)AACR Annual Meeting, Anaheim, CA, US, 2005Link to PDF DocumentBiochemical analyses and molecular modelling of two aminoacidic substitutions detected in two gastrointestinal stromal tumor (GIST) patients showing acquired resistance to imatininb
2932005Pricl S., Ferrone M., Paneni M.S., Fermeglia M.,Tamborini E., Negri T., Lagonigro M.S., Miselli F., Greco A., Pierotti M.A., Pilotti S.11: 9032s (2005)AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications, Philadelphia, PA, USALink to PDF DocumentT670X kit mutations in gastrointestinal stromal tumors: making sense of missense
2942005Pricl S., Ferrone M., Paneni M.S., Cosoli P., Fermeglia M., Pierotti M.A., Pilotti S., Tamborini E.CD 2: 393a (2005)AIChE Annual Meeting 2005, Cincinnati, OH, USALink to PDF DocumentChanges and challenges: gist, mutated c-kit and imatinib resistance
2952005Paneni M.S., Ferrone M., Cosoli P., Fermeglia M., Pricl M.CD 2: 393b (2005)AIChE Annual Meeting 2005, Cincinnati, OH, USALink to PDF DocumentWhere are we in hiv research? a novel, computer-based strategy predicting resistance to HIV-1 NNRTIs
2962005Toth R., Ferrone M., Miertus S:, Chiellini E., Fermeglia M., Pricl S.CD 2: 414g (2005)AIChE Annual Meeting 2005, Cincinnati, OH, USALink to PDF DocumentNano-scaled inorganic/biopolymer composites: molecular modeling vistas
2902005Ferrone M., Fermeglia M., Pricl S., Cosentino C., Amato F., Ferrari M.1: 63 (2005)Euronanoforum 2005 - Nanotechnology and the Health of the EU Citizen in 2020, Edimburgh, UKLink to PDF DocumentDiffusion of proteins in nanochannels. A many-scale simulation approach
2912005Ferrone M., Paneni M.S., Cosoli P., Fermeglia M., Tamborini E., Pierotti M.A., Pilotti S., Pricl S.1:64 (2005)Euronanoforum 2005 - Nanotechnology and the Health of the EU Citizen in 2020, Edimburgh, UKLink to PDF DocumentFighting cancer at the nanoscale: computational structural biology and the Bcr-Abl/Imatinib paradigm
2922005Cosoli P., Ferrone M., Paneni M.S., Fermeglia M., Pricl S.1:90 (2005)Euronanoforum 2005 - Nanotechnology and the Health of the EU Citizen in 2020, Edimburgh, UKLink to PDF DocumentTake a walk on the nano side: structural and energetical analysis of ATP-binding pocket mutations of the cardiac beta-myosin heavy chain implicated in familial hypertrophic cardiomyopathy
3012005Zampieria D., Mamolo M.G., Vio L., Tonzara E., Pricl S., Ferrone M., Scialino G., Banfi E.1: P68 (2005)Second Joint Italian-Swiss Meeting on Medicinal Chemistry, Modena, IT, 2005Link to PDF DocumentSynthesis, antifungal and antimycobacterial activities of new bisimidazole derivatives
3022005Carta A., Loriga M., Paglietti G., Ferrone M., Pricl S., Piano M.A., Meloni M. La Colla P.1:P42 (2005)Second Joint Italian-Swiss Meeting on Medicinal Chemistry, Modena, IT, 2005Link to PDF DocumentSynthesis and antiviral activity of 4,7-Phenantroline derivatives against RNA Viruses
3032005Ferrone M., Pricl S., Fermeglia M., Paneni M.S., Angusti A., Ciliberti N., Buzzoni L., Durini E., Vertuani S., Manfredini S., Loddo R., La Colla P.1: 32-33 (2005)The 6th biennial meeting in this HEP DART series, HEP DART 2005 Frontiers in Drug Development for Viral Hepatitis, Big Island, Hawaii, US, 2005Link to PDF DocumentThree-dimensional Pharmacophore Modeling of Hindered Nucleoside Analogs (HNAs) as Inhibitors of the Hepatitis C virus NS5B Polymerase
3042005Pricl S., Fermeglia M., Ferrone M., Paneni M.S., Cosoli P., Costi R., Roux A., Artico M., Di Santo R.1: 36-37 (2005)The 6th biennial meeting in this HEP DART series, HEP DART 2005 Frontiers in Drug Development for Viral Hepatitis, Big Island, Hawaii, US, 2005Link to PDF DocumentNovel Aryl Diketo Acids (ADKs) as Inhibitors of Hepatitis C Virus NS5b RNA-Dependent RNA-Polymerase: Better Understanding Through Molecular Modeling
3222005Angusti A., Auzzas L., Boido V., Canu C., Carta A., Ciliberti N., Ferrone M., Loddo R., La Colla P., Loriga M., Manfredini S., Mazzei M., Nieddu E., Paglietti G., Paneni M.S., Pricl S., Rassu G., Sparatore F., Tasso B., Vitale G.1: 37-38 (2005)The 6th biennial meeting in this HEP DART series, HEP DART 2005 Frontiers in Drug Development for Viral Hepatitis, Big Island, Hawaii, US, 2005Link to PDF DocumentNon-nucleoside anti-Flaviviridae agents from different molecular classes: a jointed experimental/modeling effort
2802004Pricl S., Coslanich A., Fermeglia M., Ferro M., Ferrone M., Paneni M.S., Tamborini E., Negri T., Lagonigro S., Greco A., Gabanti E., Pierotti M.A., Pilotti S.1: 187 (2004)16th EORTC-NCI-AARC Symposium on "Molecular Targets and Cancer Therapeutics", Geneve, Switzerland, 2004Link to PDF DocumentAnalogies in imatinib-resistant threonine-to-isoleucine mutation in bcr-abl, kit and pdgfra: a combined experimental/computational approach
2722004Pricl S., Fermeglia M., Ferrone M., Coslanich A., Paneni M.S, Tambori E., Pilotti S.1:67g (2004)AIChE Annual Meeting 2004, Austin, Tx, USALink to PDF DocumentA new mutation affecting the ATP pocket of kit receptor in patients with GIST showing acquired resistance to Imatinib: a coupled experimental and modeling investigation
2762004Paneni M.S., Ferrone M., Coslanich A:, Fermeglia M., Pricl S., Miertus S., Frecer V., Carniel E., Mestroni L.1:448b (2004)AIChE Annual Meeting 2004, Austin, Tx, USALink to PDF DocumentA talk on the motor side. The free energy for mutating V186 and F244 to Leucine in beta-myosin and its ATP binding
2772004Pricl S., Fermeglia M., Ferrone M., Coslanich A., Paneni M.S., Manfredini S., Angusti A., La Colla P., Mura M.1:448a (2004)AIChE Annual Meeting 2004, Austin, Tx, USALink to PDF Document"Fatty" nucleoside analogs as HCV NS5b inhibitors
2782004Pricl S., Fermeglia M., Coslanich A., Ferrone M., Paneni M.S., Caliceti P., Salmaso S., Semenzato S.1: 494b (2004)AIChE Annual Meeting 2004, Austin, Tx, USALink to PDF DocumentDesign, synthesis and characterization of folate-cyclodextrin bioconjugate for active drug delivery: results from combined computational and experimental efforts
2612004Pricl S., Ferrone M., Paneni M.S., Angusti A., Manfredini S., La Colla P., Mura M.1: 115-118 (2004)Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentDesign, synthesis and activity of hindered nucleoside analogs with anti-Flaviviridae activity, and their interaction with RdRp
2622004Pricl S., Ferrone M., Paneni M.S., Tamborini E., Pilotti S., Pierotti M.A.1: 145-148 (2004)Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentIs tailor-fitting always the best choice? The case of mutations in GISTs and Imatinib
2632004Paneni M.S., Ferrone M., Pricl S., Carniel E., Miertus S., Frecer V., Mestroni L.1: 253-256 (2004)Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentGenotype-phenotype correlations of myosin mutations: a molecular simulation study
2642004Ferrone M., Pricl S., Paneni M.S., Tamborini E., Pilotti S., Pierotti M.A.1: 273-276 (2004)Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentP53 mutations in sporadic and NF1 related malignant peripheral nerve sheath tumors (MPNST): from clinical evidences to a molecular rationale
2662004Pricl S.2: 1191-1194Convegno GRICU Nuove frontiere di applicazione delle metodologie dell'ingegneria chimicaLink to PDF DocumentFree energy calculations in biological systems
2832004Pricl S., Coslanich A., Fermeglia M., Ferrone M., Paneni M.S., Loddo R., Cabizza A., Sanna G., Murreddu M., La Colla P.1:41-42 (2004)HIV Dart 2004, Montego Bay, Jamaica 2004Link to PDF DocumentPrediction fo HIV-1 resistance to NNRITs: a computer-aided molecular-based rationale
3152004Banfi E., Ferrone M., Mamolo M., Pricl S., Scialino G., Vio L., Zampieri D.Third Croatian Congress of Microbiology with International Participation, Porec, Croatia, 2004Molecular modeling in drug design: new chemicals with antitubercolar, antifungal, antibacterial activity: synthesis and MIC evaluation; experimental and computational approach
3162004Zampieri D., Mamolo M., Vio L., Ferrone M., Pricl S., Scialino G., Banfi E.1: 047 (2004)Wolrd Conference on Magic Bullets Celebrating Paul Ehrlich's 150th Birthday, Nurnberg, Germany, 2004Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach
2242003Pricl S., Ferrone M., Fermeglia M., Tamborini E., Delia D., Pierotti M.A., Pilotti S.CD 1: MEDI 74 (2003)225th ACS National Meeting, New Orleans, Usa, 2003Link to PDF DocumentC-kit mutants in GISTs and their interaction with STI 571: insights from computer simulations and clinical trials
2252003Pricl S., Ferrone M., Fermeglia M., Laurent L., Tamborini E., Delia D., Pierotti M.A., Pilotti S.CD 1: MEDI 140 (2003)225th ACS National Meeting, New Orleans, Usa, 2003Link to PDF DocumentCompuational alanine scanning to probe DNA-wild typeand mutant P53 interactions
2262003Pricl S., Ferrone M., Fermeglia M., Lodi A.CD 1: CARB 69 (2003)225th ACS National Meeting, New Orleans, Usa, 2003Link to PDF DocumentMolecular dynamics and free energy analyses of the interactions between b-cyclodextrin and some anticancer drugs
2282003Ferrone M., Coslanich A., Fermeglia M., Felluga F., Pitacco G., Valentin E., Pricl S.1: 55 (2003)5° Convegno FISV, Rimini, I, 2003Link to PDF DocumentEnantioselectivity of alpha-chytripsyn towards 4,5-disubstituted-gamma-lactams: a new perspective from molecular simulations
2402003Pricl S., Coslanich A., Fermeglia M., Ferrone M., Albertini V., Bonadiman L., Tamborini E., Pierotti M.A., Pilotti S.1: 107g (2003)AIChE Annual Meeting 2003, S. Francisco, USALink to PDF DocumentA Tumor (GIST), a Mutated Gene (c-kit), and a Molecular Inhibitor (Imatinib): Insights from Computer Simulations
2412003Pricl S., Coslanich A., Fermeglia M., Ferrone M., Metullio L., Fuchs S.1: 472b (2003)AIChE Annual Meeting 2003, S. Francisco, USALink to PDF DocumentTowards Dendrimers as Anticancer Drug Carriers: from in Silico to in Vivo Characterization
2442003Coslanich A., Fermeglia M., Ferrone M., Paneni M.S., Pricl S., Caliceti P., Carofiglio T., Fornasier R., Salmaso S., Semenzato A.1: session health & medicine (2003)EuroNanoForum 2003, Trieste, Italy, 2003Link to PDF DocumentIntegrated process of design, synthesis and physicochemical characterization of nanovectors for active drug delivery: the cyclodextrin-folate-bioconjugate example
2472003Coslanich A., Fermeglia M., Ferrone M., Pricl S., Tamborini E., Oggioni M., Perrone F., Pilotti S., Delia D., Pierotti M.A.1: session health & medicine (2003)EuroNanoForum 2003, Trieste, Italy, 2003Link to PDF DocumentHow the Angstrom modifies the nano: effect of point mutations on the nanodimensional structure of human TP53 point mutations
2322003Pricl S., Fermeglia M., Ferrone M., Manfredini S., Angusti A., Di Santo R., Frecer V., Miertus S.1:1 (2003)FOMMS2003, Foundation of Molecular Modelling and Simulation, Keyston Resort, CO, USA, (2003)Link to PDF DocumentComputer-assisted design of new, potential HCV inhibitors
2422003S. Pricl, A. Coslanich, M. Fermeglia, M. Ferrone, M. Merzek, A. Angusti, N. Ciliberti, E. Durini, S. Manfredini, Chiara Musiu, Massimo Mura, Roberta Loddo, and P. La Colla1: 30-31 (2003)HEP_DART 2003, Kanaui Island (Hawaii), US 2003Link to PDF DocumentSynthesis of a New Series of Nucleoside Analogs with Antiflaviviridae Activity and Their Interaction with RNA-Dependent RNA-Polymerase
1942002Ferrone,M., Fermeglia, M., Pricl, S.1: 323-325 (2002)16th European Conference on Thermophysical Properties, IC London UK, 2002Link to PDF DocumentChemical Engineering at the edge of life science. Selected cases of molecular simulations and free-energy calculations for biological and medical applications.
2072002Pricl S., Felluga F., Pitacco G., Valentin E., Ferrone M.CD 1: ORGN 500 (2002)224th ACS National Meeting, Boston, Usa, 2002Link to PDF DocumentEnantiomerically pure beta,gamma-disubstituted gamma-lactams: Enzyme-mediated synthesis and computational studies
2082002Manfredini S., Augusti A., Durini E., Vertuani S., Nalin F., Verri A., Spadari S., Focher F., Solaroli N., De Clercq E., Balzarini J., Ferrone M., Pricl S.CD 1: MEDI 38 (2002)224th ACS National Meeting, Boston, Usa, 2002Link to PDF DocumentRibonucleotide reductase potential inhibitors: Design, synthesis and activity of bioisosters of ribofuranosylnucleoside diphosphates
2042002Fermeglia, M., Ferrone, M., Pricl, S., Lodi, A., Caliceti, P., Salmaso, S., Fornasier, R.CD 1: MEDI 87 (2002)224th ACS National Meeting, Boston, Usa, 2002Link to PDF DocumentSynthesis, characterization and molecular modeling of a cyclodextrin-bioconjugate as anticancer drug
2052002Pricl S., Fermeglia M., Ferrone M., Tamborini E., Oggionni M., Perrone F., Delia D., Pilotti S., Pierotti M.A.CD 1: MEDI 234 (2002)224th ACS National Meeting, Boston, Usa, 2002Link to PDF DocumentDetailed Computational Study of Point Mutations of the TP53 Tumor-Suppressor Protein
2092002Di Santo R., Costi R., Artico M., Fermeglia M., Ferrone M., Lodi A., Manfredini S., Pricl S.1:215-216 (2002)23rd International symposium on the chemistry of natural products (ISCNP-23), Firenze, I, 28/7-2/8, 2002Link to PDF DocumentProbing the activity of diketoacis as HCV NS5B polymerase inhibitors via detailed molecular modeling
2032002Ferrone M., Fermeglia M., Pricl S., Tamborini E., Oggioni M., Perrone F., Delia D., Pilotti S. and Pierotti M.1: 5 (2002)4° Convegno FISV, Riva del Garda (TN), I, 2002Link to PDF DocumentHuman TP53 point mutations: structural analysis by molecular modelling
2182002Artico M., Costi R., Di Santo R., Fermeglia M., Ferrone M., Manfredini S., Pricl S.CD 1: 245g (2002)AIChE annual meeting 2002, Indianapolis, USALink to PDF DocumentCan inhibitors of HIV integrase work on HCV polymerase?
2192002Pricl S., Fermeglia M., Ferrone M., Tamborini E., Oggionni M., Perrone F., Pilotti S., Delia D., Pierotti M.A.CD 1: 299c (2002)AIChE annual meeting 2002, Indianapolis, USALink to PDF DocumentDetailed Molecular Modeling of Point Mutations of P53
2062002De Nardi P.G., Fermeglia M., Ferrone M., Frecer V., Kabelac M., Miertuš S., Pricl S.1: 10-11 (2002)Controlled Release Society CRS-Italian Chapter WORKSHOP su Bioconiugazione, Padova, Italy, 2002Link to PDF DocumentModellazione molecolare e progettazione di nuovi inibitori della serin proteasi NS3 del virus dell’HCV
2132002Fermeglia M., Ferrone M., Pricl S.1: 11-12 (2002)Controlled Release Society CRS-Italian Chapter WORKSHOP su Ciclodestrine, prorietà e applicazioni, Padova, Italy, 2002Link to PDF DocumentModelllazione molecolare e calcoli di energia libera di binding per complessi di inclusione ciclodestrina-farmaci antitumorali
2142002Pricl S., Fermeglia M., Ferrone M., Lodi A., Caliceti P., Salmaso S., Fornasier R.1: 17-18 (2002)Controlled Release Society CRS-Italian Chapter WORKSHOP su Ciclodestrine, prorietà e applicazioni, Padova, Italy, 2002Link to PDF DocumentA cyclodextrin-bioconjugate as carrier for anticancer drugs: from synthesis to molecular modeling
1902002Manfredini, S., Solaroli, N., Porcu, L., Angusti, A., Durini, E., Vertuani, S., Verri, A., Spadari, S., Focher, F., Ferrone, M., Pricl, S., De Clercq, E., Balzarini, J.1:315-318 (2002)Proceedings of the 15th International Conference on Antiviral Research (ICAR), Prague, Czech Republic, March 17-21, 2002Phosphonoacetic Acid (PPA) Ester and Amide Bioisosters of Ribofuranosylnucleoside Diphosphates as Potential Ribonucleotide Reductase Inhibitors: Design, Synthesis and Activity.
2152002Angusti A., Manfredini S., Veronese A. C., Durini E., Vertuani S., Nalin F., Solaroli N., Pricl S., Ferrone M., Mura M., Musiu C., Piano M. A., Poddesu B., Marturana F., La Colla P.CD 1:1(2002)XVI Convegno Nazionale Divisione Chimica Farmaceutica della Società Chimica Italiana, Sorrento, 18-22/9, 2002Progettazione, sintesi ed attività biologica di analoghi nucleosidici ad attività antiflaviviridae
1802001Felluga, F., Pricl, S.AIChE national meeting 2001, Rino, USALink to PDF DocumentMolecular Simulation of receptor/substrate interaction: the case of alpha-chymotrypsyn and beta-carbomethoxy-gamma-lactems.
1812001De Nardi, P., Fermeglia, M., Pricl, S., Frecer, V., Miertus, S.AIChE national meeting 2001, Rino, USALink to PDF DocumentComputer design of new inhibitors of hepatitis C virus enzymes.
1822001Gelmetti, S., Fermeglia, M., Pricl, S.AIChE national meeting 2001, Rino, USALink to PDF DocumentModeling of molecular interactions and inclusion phenomena of aminoacids and nucleotides in a synthetic dendrimer.
1622001M. Fermeglia, A. Lodi, S. PriclAIChE national meeting 2001, Rino, USALink to PDF DocumentCyclodextrin as a template for molecular assembly: inclusion complexes with anti - cancer drugs
1632001M. Fermeglia, M. Fratta, S. PriclAIChE national meeting 2001, Rino, USALink to PDF DocumentBSE prion fragment (90-231): pH induced conformational changes and binding with potential inhibitors by molecular dynamics
1652001Fermeglia M., Ferrone M., Pricl S.AIChE national meeting 2001, Rino, USALink to PDF DocumentBiotechnological dendrimers with a protopophynic core: a molecular dynamic study
1682001Pricl S., Fermeglia M., Fratta M., Forloni G., D'Ursi P.1:555-558 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentStudio dell'interazione di potenziali inibitori con il prione PRP (90-231) della BSE tramite tecniche di dinamica molecolare
1692001Pricl S., Fermeglia M., Lodi A.1:691-694 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentSimulazione molecolare di complessi host-guest: applicazione al caso ciclodestrine - farmaci antitumorali
1702001Pricl S., Fermeglia M., Ferrone M.CD 1: 535-538 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentDendrimeri biotecnologici a nucleo protoporfirinico: studio di dinamica molecolare
1732001Pricl S., Fermeglia M., Mazzurco A.1:706-709 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentModellazione molecolare della complessazione di fans in ciclodestrine modificate
1782001Pricl, S., Felluga, F.1:37-40 (2001)XV Convegno Italiano di Scienza e Tecnologia della Macromolecole, 2001Link to PDF DocumentSimulazione molecolare delle interazioni recettore/substrato: il caso dell’alfa-chimotripsina e i beta-carbometossi-gamma-lattami
991996Fermeglia M., Fele L.www.egc.ac.uk (1996)EGC2 Virtual Conference, Internet, 1997Protein separation by partitioning in poly(ethylene glycol) + dextran + water.
941995Fermeglia M.1:1(1995)Impiego dei simulatori nei processi chimici, Padova, Italy, 1995La cristallizzazione nell' industria farmaceutica: simulazione di processo.
871994Fermeglia M., Fele L.1: 92 (1994)6th European Symposium on Thermal Analysis and Calorimetry, Grado, Italy, 1994Protein partitions in aqueous two phase systems.